These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34336857)

  • 1. Physiological Functions of Mcl-1: Insights From Genetic Mouse Models.
    Chin HS; Fu NY
    Front Cell Dev Biol; 2021; 9():704547. PubMed ID: 34336857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mcl-1 and Bcl-xL are essential for survival of the developing nervous system.
    Fogarty LC; Flemmer RT; Geizer BA; Licursi M; Karunanithy A; Opferman JT; Hirasawa K; Vanderluit JL
    Cell Death Differ; 2019 Aug; 26(8):1501-1515. PubMed ID: 30361616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCL-1 is required throughout B-cell development and its loss sensitizes specific B-cell subsets to inhibition of BCL-2 or BCL-XL.
    Vikström IB; Slomp A; Carrington EM; Moesbergen LM; Chang C; Kelly GL; Glaser SP; Jansen JH; Leusen JH; Strasser A; Huang DC; Lew AM; Peperzak V; Tarlinton DM
    Cell Death Dis; 2016 Aug; 7(8):e2345. PubMed ID: 27560714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding affinity of pro-apoptotic BH3 peptides for the anti-apoptotic Mcl-1 and A1 proteins: Molecular dynamics simulations of Mcl-1 and A1 in complex with six different BH3 peptides.
    Modi V; Sankararamakrishnan R
    J Mol Graph Model; 2017 May; 73():115-128. PubMed ID: 28279820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells.
    Song L; Coppola D; Livingston S; Cress D; Haura EB
    Cancer Biol Ther; 2005 Mar; 4(3):267-76. PubMed ID: 15753661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtle Changes in the Levels of BCL-2 Proteins Cause Severe Craniofacial Abnormalities.
    Grabow S; Kueh AJ; Ke F; Vanyai HK; Sheikh BN; Dengler MA; Chiang W; Eccles S; Smyth IM; Jones LK; de Sauvage FJ; Scott M; Whitehead L; Voss AK; Strasser A
    Cell Rep; 2018 Sep; 24(12):3285-3295.e4. PubMed ID: 30232009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of MCL-1 by obatoclax sensitizes Sp2/0-Ag14 hybridoma cells to glutamine deprivation-induced apoptosis.
    Harnett CC; Abusneina A; Clément J; Gauthier ER
    Cell Biochem Funct; 2015 Jul; 33(5):334-40. PubMed ID: 26178811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1.
    Mallick S; Patil R; Gyanchandani R; Pawar S; Palve V; Kannan S; Pathak KA; Choudhary M; Teni TR
    J Pathol; 2009 Feb; 217(3):398-407. PubMed ID: 19009587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Mcl-1 in Embryonic Neural Precursor Cell Apoptosis.
    Flemmer RT; Connolly SP; Geizer BA; Opferman JT; Vanderluit JL
    Front Cell Dev Biol; 2021; 9():659531. PubMed ID: 33959612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-apoptotic Bcl-XL but not Mcl-1 contributes to protection against virus-induced apoptosis.
    Ohmer M; Weber A; Sutter G; Ehrhardt K; Zimmermann A; Häcker G
    Cell Death Dis; 2016 Aug; 7(8):e2340. PubMed ID: 27537523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines.
    Klenke S; Akdeli N; Stelmach P; Heukamp L; Schulte JH; Bachmann HS
    BMC Cancer; 2019 Mar; 19(1):243. PubMed ID: 30885150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance.
    Spinner S; Crispatzu G; Yi JH; Munkhbaatar E; Mayer P; Höckendorf U; Müller N; Li Z; Schader T; Bendz H; Hartmann S; Yabal M; Pechloff K; Heikenwalder M; Kelly GL; Strasser A; Peschel C; Hansmann ML; Ruland J; Keller U; Newrzela S; Herling M; Jost PJ
    Leukemia; 2016 Jul; 30(7):1520-30. PubMed ID: 27055871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mcl-1 is an important therapeutic target for oral squamous cell carcinomas.
    Maji S; Samal SK; Pattanaik L; Panda S; Quinn BA; Das SK; Sarkar D; Pellecchia M; Fisher PB; Dash R
    Oncotarget; 2015 Jun; 6(18):16623-37. PubMed ID: 26009874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR signaling defines Mcl⁻1 survival dependency in neuroblastoma.
    Nalluri S; Peirce SK; Tanos R; Abdella HA; Karmali D; Hogarty MD; Goldsmith KC
    Cancer Biol Ther; 2015; 16(2):276-86. PubMed ID: 25756510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Cancer Drug Development: Targeting Induced Myeloid Cell Leukemia-1 (Mcl-1) Differentiation Protein.
    Abid M; Sonawane YA; Contreras JI; Rana S; Natarajan A
    Curr Med Chem; 2017; 24(40):4488-4514. PubMed ID: 28901269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mcl-1 antagonism is a potential therapeutic strategy in a subset of solid cancers.
    Modugno M; Banfi P; Gasparri F; Borzilleri R; Carter P; Cornelius L; Gottardis M; Lee V; Mapelli C; Naglich JG; Tebben A; Vite G; Pastori W; Albanese C; Corti E; Ballinari D; Galvani A
    Exp Cell Res; 2015 Mar; 332(2):267-77. PubMed ID: 25486070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1.
    Liu Y; Xie M; Song T; Sheng H; Yu X; Zhang Z
    Pigment Cell Melanoma Res; 2015 Mar; 28(2):161-70. PubMed ID: 25324174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr mice.
    Anstee NS; Vandenberg CJ; Campbell KJ; Hughes PD; O'Reilly LA; Cory S
    Cell Death Differ; 2017 Mar; 24(3):397-408. PubMed ID: 27813531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient mice.
    Grabow S; Delbridge AR; Valente LJ; Strasser A
    Blood; 2014 Dec; 124(26):3939-46. PubMed ID: 25368374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual inhibition of BCL-XL and MCL-1 is required to induce tumour regression in lung squamous cell carcinomas sensitive to FGFR inhibition.
    Weeden CE; Ah-Cann C; Holik AZ; Pasquet J; Garnier JM; Merino D; Lessene G; Asselin-Labat ML
    Oncogene; 2018 Aug; 37(32):4475-4488. PubMed ID: 29743589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.